Cargando…
Use of dual-transfection for programmed death cell protein 1 disruption mediated by CRISPR-Cas9 in human peripheral blood mononuclear cells
OBJECTIVE(S): Checkpoint blocking is considered a revolutionary method in cancer treatment. This method eliminates cancer cells by maintaining the sensitivity of immune cells. Today, cell therapy through checkpoint blocking is known as the most efficient method of cancer treatment. The programmed ce...
Autores principales: | Alambeladi, SeyedAli, Hosseiny, SeyedEbrahim, Jafarinia, Mojtaba, Dianatpour, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894638/ https://www.ncbi.nlm.nih.gov/pubmed/33643569 http://dx.doi.org/10.22038/ijbms.2020.48566.11146 |
Ejemplares similares
-
Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancer
por: Ahmadi-Balootaki, Soraya, et al.
Publicado: (2022) -
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
por: Han, Xin, et al.
Publicado: (2015) -
CRISPR/Cas9-mediated knockout of MLL5 enhances apoptotic effect of cisplatin in HeLa cells in vitro
por: Pirouzfar, Mohammad, et al.
Publicado: (2020) -
Dystrophin gene editing by CRISPR/Cas9 system in human skeletal muscle cell line (HSkMC)
por: Dara, Mahintaj, et al.
Publicado: (2021) -
Using CRISPR/Cas9 System to Knock out Exon 48 in DMD Gene
por: Dara, Mahintaj, et al.
Publicado: (2021)